Computerized Assessment of Breast Lesion Malignancy Using DCE-MRI Robustness Study on Two Independent Clinical Datasets from Two Manufacturers
Overview
Affiliations
Rationale And Objectives: To conduct a preclinical evaluation of the robustness of our computerized system for breast lesion characterization on two breast magnetic resonance imaging (MRI) databases that were acquired using scanners from two different manufacturers.
Materials And Methods: Two clinical breast MRI databases were acquired from a Siemens scanner and a GE scanner, which shared similar imaging protocols and retrospectively collected under an institutional review board-approved protocol. In our computerized analysis system, after a breast lesion is identified by the radiologist, the computer performs automatic lesion segmentation and feature extraction and outputs an estimated probability of malignancy. We used a Bayesian neural network with automatic relevance determination for joint feature selection and classification. To evaluate the robustness of our classification system, we first used Database 1 for feature selection and classifier training, and Database 2 to test the trained classifier. Then, we exchanged the two datasets and repeated the process. Area under the receiver operating characteristic curve (AUC) was used as a performance figure of merit in the task of distinguishing between malignant and benign lesions.
Results: We obtained an AUC of 0.85 (approximate 95% confidence interval [CI] 0.79-0.91) for (a) feature selection and classifier training using Database 1 and testing on Database 2; and an AUC of 0.90 (approximate 95% CI 0.84-0.96) for (b) feature selection and classifier training using Database 2 and testing on Database 1. We failed to observe statistical significance for the difference AUC of 0.05 between the two database conditions (P = .24; 95% confidence interval -0.03, 0.1).
Conclusion: These results demonstrate the robustness of our computerized classification system in the task of distinguishing between malignant and benign breast lesions on dynamic contrast-enhanced (DCE) MRI images from two manufacturers. Our study showed the feasibility of developing a computerized classification system that is robust across different scanners.
Vascularity and Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging.
Frankhouser D, Dietze E, Mahabal A, Seewaldt V Front Radiol. 2023; 1:735567.
PMID: 37492179 PMC: 10364989. DOI: 10.3389/fradi.2021.735567.
Gasulla O, Ledesma-Carbayo M, Borrell L, Fortuny-Profitos J, Mazaira-Font F, Allende J Front Bioeng Biotechnol. 2023; 11:1010679.
PMID: 37152658 PMC: 10157246. DOI: 10.3389/fbioe.2023.1010679.
Li H, Whitney H, Ji Y, Edwards A, Papaioannou J, Liu P J Med Imaging (Bellingham). 2022; 9(3):034502.
PMID: 35685120 PMC: 9168763. DOI: 10.1117/1.JMI.9.3.034502.
Clinical Artificial Intelligence Applications: Breast Imaging.
Hu Q, Giger M Radiol Clin North Am. 2021; 59(6):1027-1043.
PMID: 34689871 PMC: 9075017. DOI: 10.1016/j.rcl.2021.07.010.
Radiomics methodology for breast cancer diagnosis using multiparametric magnetic resonance imaging.
Hu Q, Whitney H, Giger M J Med Imaging (Bellingham). 2020; 7(4):044502.
PMID: 32864390 PMC: 7444714. DOI: 10.1117/1.JMI.7.4.044502.